Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Acron invests $80 mln in reconstruction of urea units

12/5/23 AKRN

Lukoil will consider the possibility of selling the Burgas refinery

12/5/23 LKOH

Shareholders of Levenhuk approved dividends

12/5/23 LVHK

Abrau-Durso increases production at the winery in Azerbaijan

12/5/23 ABRD

Shareholders of KuibyshevAzot approved dividends

12/5/23 KAZT

LSR bought 20% of the Shabolovka development project

12/5/23 LSRG

Trading volume on Moscow Exchange in November increased by 69% year-on-year

12/4/23 MOEX

Moscow Exchange supported minority shareholders of Solikamsk Magnesium Plant

12/4/23 MOEX

Moscow Exchange supported minority shareholders of Solikamsk Magnesium Plant

12/4/23 MGNZ

Baring Vostok cannot leave Russia because of Ozon

12/4/23 OZON